Village Global Podcast [Highlight] What Happens to Society When We Live to 100? with Celine Halioua
Feb 24, 2026
Celine Halioua, founder and CEO of Loyal and longevity entrepreneur, discusses biological interventions and how approved drugs could reframe aging as treatable. She talks about cognitive aging shaping cultural preferences, the social effects of healthier parents on mobility, and financial and planning implications of longer healthy lifespans.
AI Snips
Chapters
Transcript
Episode notes
Drug Approval Will Reframe Aging As Treatable
- FDA-approved drugs will reframe aging as an intervenable biological process rather than lifestyle optimization.
- Celine Halioua argues a drug approval will shift longevity from supplements/tests to measurable pathological aging with physiological vs chronological distinction.
Adopting Wilma The Snaggle‑Toothed Dog
- Celine unexpectedly adopted a young Rottweiler mix named Wilma aka Squishy after postponing visits to the shelter.
- She hadn’t planned a puppy, drove home without a dog bed, and adopted after seeing a snaggle-toothed shelter dog from SFSPCA.
Longevity Will Shift Long Tails Not Create Immortals
- Radical lifespan extension is biologically possible but likely rare due to complexity and intervention tradeoffs.
- Halioua frames longevity gains as shifting long-tail outcomes rightward rather than widespread immediate 1000‑year lives.